- Home
- CELC vs EIM Comparison
CELC vs EIM Comparison
Compare CELC & EIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- EIM
- Stock Information
- Founded
- CELC 2011
- EIM 2002
- Country
- CELC United States
- EIM United States
- Employees
- CELC N/A
- EIM N/A
- Industry
- CELC Medical Specialities
- EIM Finance/Investors Services
- Sector
- CELC Health Care
- EIM Finance
- Exchange
- CELC Nasdaq
- EIM Nasdaq
- Market Cap
- CELC 440.0M
- EIM 522.9M
- IPO Year
- CELC 2017
- EIM N/A
- Fundamental
- Price
- CELC $13.77
- EIM $9.54
- Analyst Decision
- CELC Strong Buy
- EIM
- Analyst Count
- CELC 6
- EIM 0
- Target Price
- CELC $30.67
- EIM N/A
- AVG Volume (30 Days)
- CELC 245.9K
- EIM 215.2K
- Earning Date
- CELC 08-13-2025
- EIM 01-01-0001
- Dividend Yield
- CELC N/A
- EIM 4.32%
- EPS Growth
- CELC N/A
- EIM N/A
- EPS
- CELC N/A
- EIM N/A
- Revenue
- CELC N/A
- EIM N/A
- Revenue This Year
- CELC N/A
- EIM N/A
- Revenue Next Year
- CELC N/A
- EIM N/A
- P/E Ratio
- CELC N/A
- EIM N/A
- Revenue Growth
- CELC N/A
- EIM N/A
- 52 Week Low
- CELC $7.58
- EIM $8.61
- 52 Week High
- CELC $19.77
- EIM $10.51
- Technical
- Relative Strength Index (RSI)
- CELC 59.12
- EIM 49.93
- Support Level
- CELC $13.47
- EIM $9.42
- Resistance Level
- CELC $14.57
- EIM $9.49
- Average True Range (ATR)
- CELC 0.65
- EIM 0.06
- MACD
- CELC -0.04
- EIM -0.00
- Stochastic Oscillator
- CELC 36.65
- EIM 59.09
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About EIM Eaton Vance Municipal Bond
Eaton Vance Municipal Bond Fund is a non-diversified closed-end management investment company. It consists of Municipal bond fund, California municipal bond fund, and New York municipal bond fund. The company's investment objective is to provide current income exempt from regular federal income tax, alternative minimum tax, and taxes in specified states. Its investment plan is to invest in higher quality bonds.